0 CAD 0.00
items in your cartto quote Checkout
Ooops no items were found.
Try something else.
Ok
Loading…
<p>The Rapid Response<sup>™</sup> COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigen is generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection, and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management.</p> <p>Pursuant to section 5 of the Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19, made by the Minister of Health on March 18, 2020, the Rapid Response<sup>™</sup> COVID-19 Antigen Rapid Test Device is now authorized for sale or importation in Canada.</p> <p><strong>Contents</strong></p> <ul> <li>Individually Packed Test Devices</li> <li>Extraction Buffer</li> <li>Extraction Tube</li> <li>Nozzle with Filter</li> <li>Tube Stand</li> <li>Individually Packed Swabs</li> <li>Package Insert</li> </ul> <p><strong>Details</strong></p> <ul> <li>Sample: Nasal / Nasopharyngeal secretions</li> <li>Format: Cassette</li> <li>Quantity: 5 Tests/Kit</li> <li>Time To Result: 15 minutes</li> <li>Storage Condition: 2-30°C/36-86°F</li> <li>Test Principle: Immunochromatographic Assay</li> </ul> <p><strong>Users</strong></p> <ul> <li>The test is for <em>in vitro</em> diagnostic use for professional and self-testing purposes</li> <li>These tests are for use by laboratory or healthcare professionals, in addition to home testing (or self-testing)</li> <li>The Rapid Response® COVID-19 Antigen Rapid Test Device is authorized for use with nasal and nasopharyngeal secretions</li> </ul> <p><strong>Self-Testing </strong></p> <p>Note: Each Province/Territory has different guidelines for Self-Testing, we encourage you to consult with your regulatory body before purchasing</p> <p> For <strong>Ontario:</strong> </p> <ul> <li>Click <a href="https://www.ontariohealth.ca/COVID-19/Health-System-Response-Resources">here</a> to view Ontario's Training & Resources Information Guide to Self-Testing</li> <li><strong>BTNX Rapid Response Antigen Test</strong> Resources <ul> <li><a href="https://www.ontariohealth.ca/sites/ontariohealth/files/2021-10/BTNX%20-%20how%20to%20create%20mini%20kits%20for%20self-screening.pdf">How To Create Mini Kits</a></li> <li><a href="https://www.ontariohealth.ca/sites/ontariohealth/files/2021-10/BTNX%20Self%20Screening%20Instructions_v4.1.pdf">Download Instructions</a></li> </ul> </li> <li>View the video above or see <a href="https://youtu.be/F7m8L6Tq498">here</a> for a demonstration on how to perform a COVID-19 Antigen Rapid Test</li> </ul>

Rapid Response™ COVID-19 Antigen Rapid Test Device 5/Box

Item Code: 150-COV19C5
Category Antigen Testing
Manufacturer Ref COV-19C5

Description

The Rapid Response COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigen is generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection, and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management.

Pursuant to section 5 of the Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19, made by the Minister of Health on March 18, 2020, the Rapid Response COVID-19 Antigen Rapid Test Device is now authorized for sale or importation in Canada.

Contents

  • Individually Packed Test Devices
  • Extraction Buffer
  • Extraction Tube
  • Nozzle with Filter
  • Tube Stand
  • Individually Packed Swabs
  • Package Insert

Details

  • Sample: Nasal / Nasopharyngeal secretions
  • Format: Cassette
  • Quantity: 5 Tests/Kit
  • Time To Result: 15 minutes
  • Storage Condition: 2-30°C/36-86°F
  • Test Principle: Immunochromatographic Assay

Users

  • The test is for in vitro diagnostic use for professional and self-testing purposes
  • These tests are for use by laboratory or healthcare professionals, in addition to home testing (or self-testing)
  • The Rapid Response® COVID-19 Antigen Rapid Test Device is authorized for use with nasal and nasopharyngeal secretions

Self-Testing 

Note: Each Province/Territory has different guidelines for Self-Testing, we encourage you to consult with your regulatory body before purchasing

 For Ontario: 

  • Click here to view Ontario's Training & Resources Information Guide to Self-Testing
  • BTNX Rapid Response Antigen Test Resources
  • View the video above or see here for a demonstration on how to perform a COVID-19 Antigen Rapid Test

Specifications

Made In

CA

Brand

Rapid Response

Category

Antigen Testing

Starting from
CAD 60.90 / BX
/
5
LIST PRICE CAD 60.90
%
- +
Compare
<p>The Rapid Response<sup>™</sup> COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigen is generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection, and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management.</p> <p>Pursuant to section 5 of the Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19, made by the Minister of Health on March 18, 2020, the Rapid Response<sup>™</sup> COVID-19 Antigen Rapid Test Device is now authorized for sale or importation in Canada.</p> <p><strong>Contents</strong></p> <ul> <li>Individually Packed Test Devices</li> <li>Extraction Buffer</li> <li>Extraction Tube</li> <li>Nozzle with Filter</li> <li>Tube Stand</li> <li>Individually Packed Swabs</li> <li>Package Insert</li> </ul> <p><strong>Details</strong></p> <ul> <li>Sample: Nasal / Nasopharyngeal secretions</li> <li>Format: Cassette</li> <li>Quantity: 5 Tests/Kit</li> <li>Time To Result: 15 minutes</li> <li>Storage Condition: 2-30°C/36-86°F</li> <li>Test Principle: Immunochromatographic Assay</li> </ul> <p><strong>Users</strong></p> <ul> <li>The test is for <em>in vitro</em> diagnostic use for professional and self-testing purposes</li> <li>These tests are for use by laboratory or healthcare professionals, in addition to home testing (or self-testing)</li> <li>The Rapid Response® COVID-19 Antigen Rapid Test Device is authorized for use with nasal and nasopharyngeal secretions</li> </ul> <p><strong>Self-Testing </strong></p> <p>Note: Each Province/Territory has different guidelines for Self-Testing, we encourage you to consult with your regulatory body before purchasing</p> <p> For <strong>Ontario:</strong> </p> <ul> <li>Click <a href="https://www.ontariohealth.ca/COVID-19/Health-System-Response-Resources">here</a> to view Ontario's Training & Resources Information Guide to Self-Testing</li> <li><strong>BTNX Rapid Response Antigen Test</strong> Resources <ul> <li><a href="https://www.ontariohealth.ca/sites/ontariohealth/files/2021-10/BTNX%20-%20how%20to%20create%20mini%20kits%20for%20self-screening.pdf">How To Create Mini Kits</a></li> <li><a href="https://www.ontariohealth.ca/sites/ontariohealth/files/2021-10/BTNX%20Self%20Screening%20Instructions_v4.1.pdf">Download Instructions</a></li> </ul> </li> <li>View the video above or see <a href="https://youtu.be/F7m8L6Tq498">here</a> for a demonstration on how to perform a COVID-19 Antigen Rapid Test</li> </ul>

Rapid Response™ COVID-19 Antigen Rapid Test Device 5/Box

Item Code: 150-COV19C5
Category Antigen Testing
Manufacturer Ref COV-19C5

Description

The Rapid Response COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigen is generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection, and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management.

Pursuant to section 5 of the Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19, made by the Minister of Health on March 18, 2020, the Rapid Response COVID-19 Antigen Rapid Test Device is now authorized for sale or importation in Canada.

Contents

  • Individually Packed Test Devices
  • Extraction Buffer
  • Extraction Tube
  • Nozzle with Filter
  • Tube Stand
  • Individually Packed Swabs
  • Package Insert

Details

  • Sample: Nasal / Nasopharyngeal secretions
  • Format: Cassette
  • Quantity: 5 Tests/Kit
  • Time To Result: 15 minutes
  • Storage Condition: 2-30°C/36-86°F
  • Test Principle: Immunochromatographic Assay

Users

  • The test is for in vitro diagnostic use for professional and self-testing purposes
  • These tests are for use by laboratory or healthcare professionals, in addition to home testing (or self-testing)
  • The Rapid Response® COVID-19 Antigen Rapid Test Device is authorized for use with nasal and nasopharyngeal secretions

Self-Testing 

Note: Each Province/Territory has different guidelines for Self-Testing, we encourage you to consult with your regulatory body before purchasing

 For Ontario: 

  • Click here to view Ontario's Training & Resources Information Guide to Self-Testing
  • BTNX Rapid Response Antigen Test Resources
  • View the video above or see here for a demonstration on how to perform a COVID-19 Antigen Rapid Test

Specifications

Made In

CA

Brand

Rapid Response

Category

Antigen Testing

Starting from
CAD 60.90 / BX
/
5
LIST PRICE CAD 60.90
%
- +
Compare
SEARCH ×